Immuno-μSARS2 Chip: A Peptide-Based Microarray to Assess COVID-19 Prognosis Based on Immunological Fingerprints.
Saved in:
| Title: | Immuno-μSARS2 Chip: A Peptide-Based Microarray to Assess COVID-19 Prognosis Based on Immunological Fingerprints. |
|---|---|
| Authors: | Guercetti J; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Alorda M; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, 08028 Barcelona, Spain.; Department of Electronics and Biomedical Engineering, University of Barcelona, Marti i Franqués 1-11, 08028 Barcelona, Spain., Sappia L; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Galve R; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Duran-Corbera M; Multivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Pulido D; Multivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Berardi G; Multivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Royo M; Multivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Lacoma A; Servei de Microbiologia, Hospital Universitari Germans Trias i Pujol, Institut Germans Trias i Pujol, 08916 Badalona, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain., Muñoz J; Servicio de Microbiología del Laboratorio de Referencia de Catalunya, 08820 Barcelona, Spain., Padilla E; Servicio de Microbiología del Laboratorio de Referencia de Catalunya, 08820 Barcelona, Spain., Castañeda S; Servicio de Enfermedades Infecciosas del Hospital del Mar de Barcelona, COVID-MAR group, 08003 Barcelona, Spain., Sendra E; Servicio de Enfermedades Infecciosas del Hospital del Mar de Barcelona, COVID-MAR group, 08003 Barcelona, Spain., Horcajada JP; Servicio de Enfermedades Infecciosas del Hospital del Mar de Barcelona, COVID-MAR group, 08003 Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Gutierrez-Galvez A; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, 08028 Barcelona, Spain.; Department of Electronics and Biomedical Engineering, University of Barcelona, Marti i Franqués 1-11, 08028 Barcelona, Spain., Marco S; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, 08028 Barcelona, Spain.; Department of Electronics and Biomedical Engineering, University of Barcelona, Marti i Franqués 1-11, 08028 Barcelona, Spain., Salvador JP; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Marco MP; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain. |
| Source: | ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2025 Feb 21; Vol. 8 (3), pp. 871-884. Date of Electronic Publication: 2025 Feb 21 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101721411 Publication Model: eCollection Cited Medium: Internet ISSN: 2575-9108 (Electronic) Linking ISSN: 25759108 NLM ISO Abbreviation: ACS Pharmacol Transl Sci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40109734 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immuno-μSARS2 Chip: A Peptide-Based Microarray to Assess COVID-19 Prognosis Based on Immunological Fingerprints. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Guercetti+J%22">Guercetti J</searchLink>; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Alorda+M%22">Alorda M</searchLink>; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, 08028 Barcelona, Spain.; Department of Electronics and Biomedical Engineering, University of Barcelona, Marti i Franqués 1-11, 08028 Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sappia+L%22">Sappia L</searchLink>; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Galve+R%22">Galve R</searchLink>; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Duran-Corbera+M%22">Duran-Corbera M</searchLink>; Multivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pulido+D%22">Pulido D</searchLink>; Multivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Berardi+G%22">Berardi G</searchLink>; Multivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Royo+M%22">Royo M</searchLink>; Multivalent Systems for Nanomedicine (MS4N), Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lacoma+A%22">Lacoma A</searchLink>; Servei de Microbiologia, Hospital Universitari Germans Trias i Pujol, Institut Germans Trias i Pujol, 08916 Badalona, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Muñoz+J%22">Muñoz J</searchLink>; Servicio de Microbiología del Laboratorio de Referencia de Catalunya, 08820 Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Padilla+E%22">Padilla E</searchLink>; Servicio de Microbiología del Laboratorio de Referencia de Catalunya, 08820 Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Castañeda+S%22">Castañeda S</searchLink>; Servicio de Enfermedades Infecciosas del Hospital del Mar de Barcelona, COVID-MAR group, 08003 Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sendra+E%22">Sendra E</searchLink>; Servicio de Enfermedades Infecciosas del Hospital del Mar de Barcelona, COVID-MAR group, 08003 Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Horcajada+JP%22">Horcajada JP</searchLink>; Servicio de Enfermedades Infecciosas del Hospital del Mar de Barcelona, COVID-MAR group, 08003 Barcelona, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gutierrez-Galvez+A%22">Gutierrez-Galvez A</searchLink>; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, 08028 Barcelona, Spain.; Department of Electronics and Biomedical Engineering, University of Barcelona, Marti i Franqués 1-11, 08028 Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Marco+S%22">Marco S</searchLink>; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, 08028 Barcelona, Spain.; Department of Electronics and Biomedical Engineering, University of Barcelona, Marti i Franqués 1-11, 08028 Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Salvador+JP%22">Salvador JP</searchLink>; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Marco+MP%22">Marco MP</searchLink>; Nanobiotechnology for Diagnostics Group, Instituto de Química Avanzada de Cataluña, IQAC-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101721411%22">ACS pharmacology & translational science</searchLink> [ACS Pharmacol Transl Sci] 2025 Feb 21; Vol. 8 (3), pp. 871-884. <i>Date of Electronic Publication: </i>2025 Feb 21 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101721411 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2575-9108 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225759108%22">25759108 </searchLink><i>NLM ISO Abbreviation: </i>ACS Pharmacol Transl Sci <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40109734 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acsptsci.4c00727 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 871 Titles: – TitleFull: Immuno-μSARS2 Chip: A Peptide-Based Microarray to Assess COVID-19 Prognosis Based on Immunological Fingerprints. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Guercetti J – PersonEntity: Name: NameFull: Alorda M – PersonEntity: Name: NameFull: Sappia L – PersonEntity: Name: NameFull: Galve R – PersonEntity: Name: NameFull: Duran-Corbera M – PersonEntity: Name: NameFull: Pulido D – PersonEntity: Name: NameFull: Berardi G – PersonEntity: Name: NameFull: Royo M – PersonEntity: Name: NameFull: Lacoma A – PersonEntity: Name: NameFull: Muñoz J – PersonEntity: Name: NameFull: Padilla E – PersonEntity: Name: NameFull: Castañeda S – PersonEntity: Name: NameFull: Sendra E – PersonEntity: Name: NameFull: Horcajada JP – PersonEntity: Name: NameFull: Gutierrez-Galvez A – PersonEntity: Name: NameFull: Marco S – PersonEntity: Name: NameFull: Salvador JP – PersonEntity: Name: NameFull: Marco MP IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 02 Text: 2025 Feb 21 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2575-9108 Numbering: – Type: volume Value: 8 – Type: issue Value: 3 Titles: – TitleFull: ACS pharmacology & translational science Type: main |
| ResultId | 1 |